MarketBeat Instant News Alerts MarketBeat Instant News Alerts - Page 133 September 9, 2026 5:06 AM ETPopular (NASDAQ:BPOP) Raised to Strong-Buy at Zacks ResearchMarketBeatNASDAQ:BPOPRead Popular (NASDAQ:BPOP) Raised to Strong-Buy at Zacks ResearchSeptember 9, 2026 5:06 AM ETBassett Furniture Industries (NASDAQ:BSET) Downgraded to Hold Rating by Zacks ResearchMarketBeatNASDAQ:BSETRead Bassett Furniture Industries (NASDAQ:BSET) Downgraded to Hold Rating by Zacks ResearchSeptember 9, 2026 5:06 AM ETMizuho Upgrades Climb Bio (NASDAQ:CLYM) to "Strong-Buy"MarketBeatNASDAQ:CLYMRead Mizuho Upgrades Climb Bio (NASDAQ:CLYM) to "Strong-Buy"September 9, 2026 5:06 AM ETCopart (NASDAQ:CPRT) Upgraded at Zacks ResearchMarketBeatNASDAQ:CPRTRead Copart (NASDAQ:CPRT) Upgraded at Zacks ResearchSeptember 9, 2026 5:06 AM ETEikon Therapeutics (NASDAQ:EIKN) Raised to Strong-Buy at MizuhoMarketBeatNASDAQ:EIKNRead Eikon Therapeutics (NASDAQ:EIKN) Raised to Strong-Buy at MizuhoSeptember 9, 2026 5:06 AM ETGuardant Health (NASDAQ:GH) Stock Rating Upgraded by Rothschild & Co RedburnMarketBeatNASDAQ:GHRead Guardant Health (NASDAQ:GH) Stock Rating Upgraded by Rothschild & Co RedburnSeptember 9, 2026 5:06 AM ETJD.com (NASDAQ:JD) Stock Rating Lowered by Arete ResearchMarketBeatNASDAQ:JDRead JD.com (NASDAQ:JD) Stock Rating Lowered by Arete ResearchSeptember 9, 2026 5:06 AM ETMvb Financial (NASDAQ:MVBF) Upgraded at Zacks ResearchMarketBeatNASDAQ:MVBFRead Mvb Financial (NASDAQ:MVBF) Upgraded at Zacks ResearchSeptember 9, 2026 5:06 AM ETNorthrim BanCorp (NASDAQ:NRIM) Raised to Strong-Buy at Hovde GroupMarketBeatNASDAQ:NRIMRead Northrim BanCorp (NASDAQ:NRIM) Raised to Strong-Buy at Hovde GroupSeptember 9, 2026 5:06 AM ETNatera (NASDAQ:NTRA) Rating Increased to Strong-Buy at Rothschild & Co RedburnMarketBeatNASDAQ:NTRARead Natera (NASDAQ:NTRA) Rating Increased to Strong-Buy at Rothschild & Co RedburnSeptember 9, 2026 5:06 AM ETOmnicell (NASDAQ:OMCL) Stock Rating Upgraded by Zacks ResearchMarketBeatNASDAQ:OMCLRead Omnicell (NASDAQ:OMCL) Stock Rating Upgraded by Zacks ResearchSeptember 9, 2026 5:06 AM ETPalo Alto Networks (NASDAQ:PANW) Lowered to "Hold" Rating by Phillip SecuritiesMarketBeatNASDAQ:PANWRead Palo Alto Networks (NASDAQ:PANW) Lowered to "Hold" Rating by Phillip SecuritiesSeptember 9, 2026 5:06 AM ETPDD (NASDAQ:PDD) Downgraded by Arete Research to HoldMarketBeatNASDAQ:PDDRead PDD (NASDAQ:PDD) Downgraded by Arete Research to HoldSeptember 9, 2026 5:06 AM ETPenguin Solutions (NASDAQ:PENG) Cut to Hold at Zacks ResearchMarketBeatNASDAQ:PENGRead Penguin Solutions (NASDAQ:PENG) Cut to Hold at Zacks ResearchSeptember 9, 2026 5:06 AM ETPersonalis (NASDAQ:PSNL) Upgraded at Zacks ResearchMarketBeatNASDAQ:PSNLRead Personalis (NASDAQ:PSNL) Upgraded at Zacks ResearchSeptember 9, 2026 5:06 AM ETQ32 Bio (NASDAQ:QTTB) Stock Rating Upgraded by MizuhoMarketBeatNASDAQ:QTTBRead Q32 Bio (NASDAQ:QTTB) Stock Rating Upgraded by MizuhoSeptember 9, 2026 5:06 AM ETReal Brokerage (NASDAQ:REAX) Rating Increased to Hold at Zacks ResearchMarketBeatNASDAQ:REAXRead Real Brokerage (NASDAQ:REAX) Rating Increased to Hold at Zacks ResearchSeptember 9, 2026 5:06 AM ETZacks Research Upgrades Royal Gold (NASDAQ:RGLD) to HoldMarketBeatNASDAQ:RGLDRead Zacks Research Upgrades Royal Gold (NASDAQ:RGLD) to HoldSeptember 9, 2026 5:06 AM ETZacks Research Downgrades Sandisk (NASDAQ:SNDK) to HoldMarketBeatNASDAQ:SNDKRead Zacks Research Downgrades Sandisk (NASDAQ:SNDK) to HoldSeptember 9, 2026 5:06 AM ETSpaceX (NASDAQ:SPCX) Raised to "Strong-Buy" at Pivotal ResearchMarketBeatNASDAQ:SPCXRead SpaceX (NASDAQ:SPCX) Raised to "Strong-Buy" at Pivotal ResearchSeptember 9, 2026 5:06 AM ETSutro Biopharma (NASDAQ:STRO) Rating Increased to Strong-Buy at MizuhoMarketBeatNASDAQ:STRORead Sutro Biopharma (NASDAQ:STRO) Rating Increased to Strong-Buy at MizuhoSeptember 9, 2026 5:06 AM ETTheravance Biopharma (NASDAQ:TBPH) Downgraded by Zacks Research to "Hold"MarketBeatNASDAQ:TBPHRead Theravance Biopharma (NASDAQ:TBPH) Downgraded by Zacks Research to "Hold"September 9, 2026 5:06 AM ETTempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co RedburnMarketBeatNASDAQ:TEMRead Tempus AI (NASDAQ:TEM) Upgraded to Hold at Rothschild & Co RedburnSeptember 9, 2026 5:06 AM ETTG Therapeutics (NASDAQ:TGTX) Rating Lowered to "Strong Sell" at Zacks ResearchMarketBeatNASDAQ:TGTXRead TG Therapeutics (NASDAQ:TGTX) Rating Lowered to "Strong Sell" at Zacks Research Featured Articles and OffersTesla’s Robotaxi Launch Wasn’t the Moment Investors ExpectedBy Sam Quirke | September 8, 2026This sub-5 dollar stock operates next to SpaceX and Blue OriginFrom Freedom Financial (Ad)AI Token Costs Are Changing the Hardware vs. Software DebateBy Jeffrey Neal Johnson | September 6, 2026Ride-Share Reckoning: Tesla Drives Into Uber's LaneBy Jeffrey Neal Johnson | September 7, 2026AeroVironment's Record Backlog and Earnings Beat Fuel Recovery CaseBy Thomas Hughes | September 10, 2026A letter from Shannon StansberryFrom Porter & Company (Ad)3 Under-the-Radar Defense Stocks With Record BacklogsBy Dan Schmidt | September 7, 2026Moderna Just Doubled Overnight, and 2 More Healthcare Stocks Could Follow ItBy Bridget Bennett | September 6, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 133 of 424 « Most Recent‹ More Recent130131132133134135136 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
